CNS Pharmaceuticals Inc. (CNSP)
NASDAQ: CNSP
· Real-Time Price · USD
6.11
1.02 (20.04%)
At close: Aug 18, 2025, 3:59 PM
6.26
2.43%
After-hours: Aug 18, 2025, 07:57 PM EDT
20.04% (1D)
| Bid | 4.5 |
| Market Cap | 3.24M |
| Revenue (ttm) | 3.14K |
| Net Income (ttm) | -15.61M |
| EPS (ttm) | -63.64 |
| PE Ratio (ttm) | -0.1 |
| Forward PE | -0.49 |
| Analyst | Buy |
| Ask | 6.8 |
| Volume | 78,430 |
| Avg. Volume (20D) | 25,488 |
| Open | 5.31 |
| Previous Close | 5.09 |
| Day's Range | 5.11 - 6.19 |
| 52-Week Range | 4.93 - 222.00 |
| Beta | 0.76 |
About CNSP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CNSP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CNSP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 days ago
-15.59%
CNS Pharmaceuticals shares are trading lower. The ...
Unlock content with
Pro Subscription
1 month ago
-10.7%
CNS Pharmaceuticals shares are trading lower after the company announced a 1-for-12 reverse split.
1 month ago · accessnewswire.com
CNS Pharmaceuticals Participates in Virtual Investor CEO Connect SegmentHOUSTON, TX / ACCESS Newswire / July 9, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for pri...
